- Home
- CRNX vs BILL Comparison
CRNX vs BILL Comparison
Compare CRNX & BILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNX | BILL |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.7B |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CRNX | BILL |
|---|---|---|
| Price | $38.57 | $44.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 22 |
| Target Price | ★ $74.78 | $58.95 |
| AVG Volume (30 Days) | 935.7K | ★ 3.2M |
| Earning Date | 06-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 74.07 |
| EPS | N/A | ★ N/A |
| Revenue | $1,039,000.00 | ★ $1,462,570,000.00 |
| Revenue This Year | $730.30 | $14.18 |
| Revenue Next Year | $179.48 | $13.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 13.36 |
| 52 Week Low | $24.10 | $35.46 |
| 52 Week High | $57.99 | $57.21 |
Technical Indicators
Market Signals| Indicator | CRNX | BILL |
|---|---|---|
| Relative Strength Index (RSI) | 26.18 | 49.15 |
| Support Level | $33.23 | $43.89 |
| Resistance Level | $45.32 | $48.13 |
| Average True Range (ATR) | 1.87 | 2.45 |
| MACD | -0.40 | 0.25 |
| Stochastic Oscillator | 6.93 | 57.17 |
Price Performance
Historical ComparisonAbout CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About BILL BILL Holdings Inc.
BILL Holdings Inc is a provider of software-as-a-service, cloud-based payments and spend and expense management products, which allow users to automate accounts payable and accounts receivable transactions, enable businesses to easily connect with their suppliers or customers to do business, eliminate expense reports, manage cash flows and improve back office efficiency. Initial Public Offering and Follow-on Offering.